LCM
TMO icon

LCM Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

LCM Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
1,896
+23
+1% +$12.5K 0.47% 34
2025
Q4 		$1.09M Sell
1,873
-159
-8% -$89.9K 0.52% 31
2025
Q3 		$986K Buy
2,032
+1
+0% +$465 0.47% 34
2025
Q2 		$824K Buy
2,031
+5
+0.2% +$2.09K 0.43% 41
2025
Q1 		$1.01M Buy
2,026
+58
+3% +$31.4K 0.59% 33
2024
Q4 		$1.02M Buy
1,968
+5
+0.3% +$2.75K 0.58% 32
2024
Q3 		$1.21M Buy
1,963
+50
+3% +$29.6K 0.7% 29
2024
Q2 		$1.06M Buy
1,913
+35
+2% +$20.1K 0.66% 28
2024
Q1 		$1.09M Buy
1,878
+11
+0.6% +$6.17K 0.71% 28
2023
Q4 		$991K Buy
1,867
+1
+0.1% +$484 0.72% 26
2023
Q3 		$945K Buy
1,866
+107
+6% +$57K 0.77% 22
2023
Q2 		$918K Buy
1,759
+26
+2% +$14K 0.75% 24
2023
Q1 		$999K Buy
1,733
+108
+7% +$60.9K 0.87% 19
2022
Q4 		$895K Buy
1,625
+13
+0.8% +$6.89K 0.87% 21
2022
Q3 		$818K Sell
1,612
-5
-0.3% -$2.8K 0.86% 19
2022
Q2 		$878K Sell
1,617
-13
-0.8% -$7.16K 0.86% 19
2022
Q1 		$963K Buy
1,630
+23
+1% +$13.2K 0.78% 23
2021
Q4 		$1.07M Buy
1,607
+77
+5% +$48.1K 0.83% 22
2021
Q3 		$874K Sell
1,530
-14
-0.9% -$7.68K 0.74% 21
2021
Q2 		$779K Buy
1,544
+19
+1% +$8.96K 0.65% 26
2021
Q1 		$696K Sell
1,525
-83
-5% -$39.6K 0.62% 30
2020
Q4 		$750K Buy
+1,608
New +$754K 0.71% 24

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LCM Capital Management's TMO Position: Q1 2026 in Review

LCM Capital Management increased its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, buying an estimated $12.5K and bringing the position to 1,896 shares worth $932K. The position accounts for 0.47% of the portfolio, ranked #34.

LCM Capital Management first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.21M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • LCM Capital Management held 1,896 shares of Thermo Fisher Scientific worth $932K as of Q1 2026.
  • LCM Capital Management bought 23 Thermo Fisher Scientific shares in Q1 2026, an estimated $12.5K.
  • Thermo Fisher Scientific made up 0.47% of LCM Capital Management's portfolio in Q1 2026, its #34 holding.
  • LCM Capital Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • LCM Capital Management's Thermo Fisher Scientific position peaked at $1.21M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.